A significant breakthrough in cancer investigation is occurring with the use of VHH fragments to reactivate mutated p53. This vital malignant protector protein is frequently disabled in various types of cancer, causing https://mirrorbookmarks.com/story21849726/vhh-fragments-revive-p53-the-potential-approach-for-tumor-management